Microbot Medical (NASDAQ:MBOT) Issues Earnings Results

Microbot Medical (NASDAQ:MBOT) released its quarterly earnings results on Tuesday. The biotechnology company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.02), Zacks reports.

Microbot Medical Stock Down 0.6 %

Shares of NASDAQ MBOT traded down $0.01 during mid-day trading on Tuesday, reaching $1.59. 759,230 shares of the company were exchanged, compared to its average volume of 1,767,746. Microbot Medical has a 52 week low of $0.82 and a 52 week high of $3.38. The company’s 50 day moving average price is $1.75 and its 200 day moving average price is $1.30. The stock has a market capitalization of $55.24 million, a PE ratio of -1.99 and a beta of 1.60.

Analyst Upgrades and Downgrades

Separately, HC Wainwright raised their target price on shares of Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a research note on Friday, January 24th.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.